1-[(4-trifluoromethylphenyl)methyl]-1H-indole-3-carboxaldehyde | 501660-56-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-[(4-trifluoromethylphenyl)methyl]-1H-indole-3-carboxaldehyde
• 英文别名: 1-(4-(trifluoromethyl)benzyl)-1H-indole-3-carbaldehyde；1-[[4-(trifluoromethyl)phenyl]methyl]-1H-indole-3-carboxaldehyde；1-(4-trifluoromethylbenzyl)-1H-indole-3-carbaldehyde；1-[4-(trifluoromethyl)benzyl]-1H-indole-3-carbaldehyde；1-[[4-(trifluoromethyl)phenyl]methyl]indole-3-carbaldehyde
• CAS: 501660-56-6
• 化学式: C₁₇H₁₂F₃NO
• mdl: MFCD28897596
• 分子量: 303.284
• InChiKey: LTRRZJRQJBPBLI-UHFFFAOYSA-N

物化性质

• 沸点：
  439.1±45.0 °C(Predicted)
• 密度：
  1.24±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  22
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  22
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  1-[(4-trifluoromethylphenyl)methyl]-1H-indole-3-carboxaldehyde 在 lithium perchlorate 、 三乙酰氧基硼氢化钠 、 溶剂黄146 作用下， 以 二氯甲烷 、 乙腈 为溶剂， 生成 (2R,3R)-2-(2,4-difluorophenyl)-1-(1,2,4-triazol-1-yl)-3-[4-[[1-[[4-(trifluoromethyl)phenyl]methyl]indol-3-yl]methyl]piperazin-1-yl]butan-2-ol
  参考文献：
  名称：

  新型 1-卤代苄基吲哚连接的三唑衍生物作为抗真菌剂的合成和活性

  摘要：

  DOI：

  10.5012/bkcs.2011.32.1.307
• 作为产物：
  描述：

  4-(三氟甲基)苄醇 在 三溴化磷 、 sodium hydride 作用下， 以 乙醚 、 N,N-二甲基甲酰胺 、 mineral oil 为溶剂， 反应 1.0h， 生成 1-[(4-trifluoromethylphenyl)methyl]-1H-indole-3-carboxaldehyde
  参考文献：
  名称：

  姜黄素激发的吲哚类似物作为微管蛋白聚合抑制剂的合成及生物学评价

  摘要：

  在我们努力开发有效的细胞毒性剂的过程中，一系列新的姜黄素激发的吲哚类似物具有1,5-二芳基-1,4-戊二烯-3-一个系统的两侧均连接有吲哚和苯基部分。通过光谱数据合成并表征。测试了所有新合成的类似物对八种癌细胞系的细胞毒性潜能，这些细胞系分别是肺癌（A549），乳腺癌（MDA-MB-231，BT549和4T1），前列腺癌（PC-3，DU145），胃癌（ HGC-27）和宫颈癌（HeLa）。值得注意的是，在所有测试的化合物中，化合物11c，11d和11f对PC-3和BT549的IC 50抑制作用强值分别在3.12–6.34μM和4.69–8.72μM范围内。还对RWPE-1（正常前列腺）细胞进行了活性最强的化合物（11c）的测试，发现与PC-3细胞相比，该化合物是安全的。在微管蛋白聚合测定中，化合物11c和11f有效抑制微管组装，IC 50值分别为10.21±0.10和8.83±0.06μM

  DOI：

  10.1016/j.ejmech.2016.12.043

文献信息

• Design, Synthesis and Anticancer Activity of 4-Morpholinothieno[3,2-<i>d</i>]pyrimidine Derivatives Bearing Arylmethylene Hydrazine Moiety
  作者：Wufu Zhu、Xin Zhai、Qiangqiang Fu、Fei Guo、Mei Bai、Jianqiang Wang、Haiyan Wang、Ping Gong

  DOI：10.1248/cpb.c12-00342

  日期：——

  Three series of 4-morpholinothieno[3,2-d]pyrimidine derivatives containing arylmethylene hydrazine moiety (11a–f, 13a–k and 15a–h) were synthesized and their chemical structures as well as the relative stereochemistry were confirmed. The synthesized compounds were evaluated for their cytotoxicity against three cancer cell lines (H460, HT-29, MDA-MB-231). Most of them exhibited moderate to significant cytotoxicity and high-selectivity against one or more cell lines, especially compounds 11c, 13b, 15f and 15g possessing dramatically increased cytotoxicity as compared with the positive controls, which were further evaluated for six other cancer cell lines and one normal cell line. The most promising compound 11c, bearing 3,4-methylenedioxy phenyl group, showed remarkable cytotoxicity against H460, HT-29 and MDA-MB-231 cell lines with IC50 values of 0.003 µM, 0.42 µM and 0.74 µM, which was 1.6- to 290-fold more potent than GDC-0941.

  合成了三系列含有芳基亚甲基肼部分的4-吗啉硫烯并[3,2-d]嘧啶衍生物（11a–f, 13a–k 和 15a–h），并确认了它们的化学结构以及相对立体化学。合成的化合物对三种癌细胞系（H460, HT-29, MDA-MB-231）的细胞毒性进行了评估。大多数化合物表现出中等到显著的细胞毒性，并对一种或多种细胞系展现出高选择性，特别是化合物11c、13b、15f和15g与阳性对照相比显示出显著提高的细胞毒性，后者进一步在另外六种癌细胞系和一种正常细胞系中进行了评估。最有前景的化合物11c，含有3,4-亚甲基二氧苯基基团，对H460、HT-29和MDA-MB-231细胞系显示出显著细胞毒性，IC50值分别为0.003 µM、0.42 µM和0.74 µM，比GDC-0941的效力提高了1.6到290倍。
• 2-Aroylimidazole compounds for treating cancer
  申请人：SBR Pharmaceuticals Corp.

  公开号：US20030096836A1

  公开（公告）日：2003-05-22

  Disclosed is a compound represented by Structural Formula (I): 1 R 1 is a substituted or unsubstituted 2-imidazolyl group which is optionally fused to a substituted or unsubstituted aryl group. Z 1 is ═O, ═S, ═NOR 11 , or ═NR 11 . R is represented by a Structural Formula selected from (II)-(VII): 2 The variables in Structural Formulas (II)-(VII) are described below.

  揭示的化合物由结构式（I）表示：1R1是一个取代或未取代的2-咪唑基团，可选择地与取代或未取代的芳基团融合。Z1是═O、═S、═NOR11或═NR11。R由从（II）到（VII）中选择的结构式表示。结构式（II）到（VII）中的变量如下描述。
• Splicing Indoles and 4,5-Dihydro-1<i>H</i>-pyrazoline Structure Gave Birth to Novel Antiviral Agents: Design, Synthesis, and Mechanism Study
  作者：Lian Bai、Chunle Wei、Zhongjie Shen、Hongfu He、Xiong Yang、Shaojie Shi、Deyu Hu、Baoan Song

  DOI：10.1021/acs.jafc.3c01005

  日期：2023.5.17

  The specific conation of our research is to invent a series of indole derivatives containing a 4,5-dihydro-1H-pyrazoline motif with effective antiviral activity. The anti-potato virus Y (PVY) activities of target compounds were systematically investigated. Most target compounds exhibited good PVY activities. Compound D40, which exhibited outstanding anti-PVY activities, was sieved using a three-dimensional

  我们研究的具体构想是发明一系列具有有效抗病毒活性的4,5-二氢-1H-吡唑啉基序的吲哚衍生物。系统研究了目标化合物的抗马铃薯 Y 病毒 (PVY) 活性。大多数目标化合物表现出良好的 PVY 活性。使用三维定量结构-活性关系筛选显示出突出的抗 PVY 活性的化合物D40 。基于抗 PVY 活性评估，发现D40的治疗和保护活性分别为 64.9% 和 60.8%，优于商业药物宁南霉素（分别为 50.2% 和 50.7%）。此外，防御酶活性和蛋白质组学结果表明D40可以增加三种关键的防御相关酶活性，调节光合生物体内的固碳途径，增强植物对PVY的抗性。因此，我们的研究表明，化合物D40可作为一种合适的作物保护农药。
• Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents
  作者：Guangcheng Wang、Chunyan Li、Lin He、Kai Lei、Fang Wang、Yuzi Pu、Zhuang Yang、Dong Cao、Liang Ma、Jinying Chen、Yun Sang、Xiaolin Liang、Mingli Xiang、Aihua Peng、Yuquan Wei、Lijuan Chen

  DOI：10.1016/j.bmc.2014.02.028

  日期：2014.4

  A new series of pyrano chalcone derivatives containing indole moiety (3-42, 49a-49r) were synthesized and evaluated for their antiproliferative activities. Among all the compounds, compound 49b with a propionyloxy group at the 4-position of the left phenyl ring and N-methyl-5-indoly on the right ring displayed the most potent cytotoxic activity against all tested cancer cell lines including multidrug resistant phenotype, which inhibits cancer cell growth with IC50 values ranging from 0.22 to 1.80 mu M. Furthermore, 49b significantly induced cell cycle arrest in G2/M phase and inhibited the polymerization of tubulin. Molecular docking analysis demonstrated the interaction of 49b at the colchicine binding site of tubulin. In experiments in vivo, 49b exerted potent anticancer activity in HepG2 human liver carcinoma in BALB/c nude mice. These results indicated these compounds are promising inhibitors of tubulin polymerization for the potential treatment of cancer. (C) 2014 Elsevier Ltd. All rights reserved.
• Analogues and Derivatives of Oncrasin-1, a Novel Inhibitor of the C-Terminal Domain of RNA Polymerase II and Their Antitumor Activities
  作者：Shuhong Wu、Li Wang、Wei Guo、Xiaoying Liu、Jinsong Liu、Xiaoli Wei、Bingliang Fang

  DOI：10.1021/jm101417n

  日期：2011.4.28

  To optimize the antitumor activity of oncrasin-1, a small molecule RNA polymerase II inhibitor, We evaluated 69 oncrasin-1 analogues for their cytotoxic activity against normal human epithelial cells and K-Ras mutant tumor cells. About 40 of those compounds were as potent as or more potent than oncrasin-1 in tumor cells and had a minimal cytotoxic effect on normal cells. Structure activity relationship analysis revealed that most of the active compounds contained either a hydroxymethyl group or an aldehyde group as a substitute at the 3-position of the indole. Both electron-donating and electron-withdrawing groups in the benzene ring were well tolerated. The hydroxymethyl compounds ranged from equipotent with to 100 times as potent as the corresponding aldehyde compounds. We tested three active analogues' effect on RNA, polymerase phosphorylation and found that they all inhibited phosphorylation of the C-terminal domain of RNA polymerase suggesting that the active compounds might act through the same mechanisms as oncrasin-1.